Cargando…

Current Trends on Protein Driven Bioinks for 3D Printing

In the last decade, three-dimensional (3D) extrusion bioprinting has been on the top trend for innovative technologies in the field of biomedical engineering. In particular, protein-based bioinks such as collagen, gelatin, silk fibroin, elastic, fibrin and protein complexes based on decellularized e...

Descripción completa

Detalles Bibliográficos
Autores principales: Veiga, Anabela, Silva, Inês V., Duarte, Marta M., Oliveira, Ana L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471984/
https://www.ncbi.nlm.nih.gov/pubmed/34575521
http://dx.doi.org/10.3390/pharmaceutics13091444
_version_ 1784574611272237056
author Veiga, Anabela
Silva, Inês V.
Duarte, Marta M.
Oliveira, Ana L.
author_facet Veiga, Anabela
Silva, Inês V.
Duarte, Marta M.
Oliveira, Ana L.
author_sort Veiga, Anabela
collection PubMed
description In the last decade, three-dimensional (3D) extrusion bioprinting has been on the top trend for innovative technologies in the field of biomedical engineering. In particular, protein-based bioinks such as collagen, gelatin, silk fibroin, elastic, fibrin and protein complexes based on decellularized extracellular matrix (dECM) are receiving increasing attention. This current interest is the result of protein’s tunable properties, biocompatibility, environmentally friendly nature and possibility to provide cells with the adequate cues, mimicking the extracellular matrix’s function. In this review we describe the most relevant stages of the development of a protein-driven bioink. The most popular formulations, molecular weights and extraction methods are covered. The different crosslinking methods used in protein bioinks, the formulation with other polymeric systems or molecules of interest as well as the bioprinting settings are herein highlighted. The cell embedding procedures, the in vitro, in vivo, in situ studies and final applications are also discussed. Finally, we approach the development and optimization of bioinks from a sequential perspective, discussing the relevance of each parameter during the pre-processing, processing, and post-processing stages of technological development. Through this approach the present review expects to provide, in a sequential manner, helpful methodological guidelines for the development of novel bioinks.
format Online
Article
Text
id pubmed-8471984
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84719842021-09-28 Current Trends on Protein Driven Bioinks for 3D Printing Veiga, Anabela Silva, Inês V. Duarte, Marta M. Oliveira, Ana L. Pharmaceutics Review In the last decade, three-dimensional (3D) extrusion bioprinting has been on the top trend for innovative technologies in the field of biomedical engineering. In particular, protein-based bioinks such as collagen, gelatin, silk fibroin, elastic, fibrin and protein complexes based on decellularized extracellular matrix (dECM) are receiving increasing attention. This current interest is the result of protein’s tunable properties, biocompatibility, environmentally friendly nature and possibility to provide cells with the adequate cues, mimicking the extracellular matrix’s function. In this review we describe the most relevant stages of the development of a protein-driven bioink. The most popular formulations, molecular weights and extraction methods are covered. The different crosslinking methods used in protein bioinks, the formulation with other polymeric systems or molecules of interest as well as the bioprinting settings are herein highlighted. The cell embedding procedures, the in vitro, in vivo, in situ studies and final applications are also discussed. Finally, we approach the development and optimization of bioinks from a sequential perspective, discussing the relevance of each parameter during the pre-processing, processing, and post-processing stages of technological development. Through this approach the present review expects to provide, in a sequential manner, helpful methodological guidelines for the development of novel bioinks. MDPI 2021-09-10 /pmc/articles/PMC8471984/ /pubmed/34575521 http://dx.doi.org/10.3390/pharmaceutics13091444 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Veiga, Anabela
Silva, Inês V.
Duarte, Marta M.
Oliveira, Ana L.
Current Trends on Protein Driven Bioinks for 3D Printing
title Current Trends on Protein Driven Bioinks for 3D Printing
title_full Current Trends on Protein Driven Bioinks for 3D Printing
title_fullStr Current Trends on Protein Driven Bioinks for 3D Printing
title_full_unstemmed Current Trends on Protein Driven Bioinks for 3D Printing
title_short Current Trends on Protein Driven Bioinks for 3D Printing
title_sort current trends on protein driven bioinks for 3d printing
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471984/
https://www.ncbi.nlm.nih.gov/pubmed/34575521
http://dx.doi.org/10.3390/pharmaceutics13091444
work_keys_str_mv AT veigaanabela currenttrendsonproteindrivenbioinksfor3dprinting
AT silvainesv currenttrendsonproteindrivenbioinksfor3dprinting
AT duartemartam currenttrendsonproteindrivenbioinksfor3dprinting
AT oliveiraanal currenttrendsonproteindrivenbioinksfor3dprinting